Xiaflex 0.9 MG vials
Ended Awarded
- Contract number
- SPE2DB25FUJSJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,568
Award facts
- Contract value 100% obligated
- $20,568.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $20,568.10 for Xiaflex 0.9 mg vials. This award, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. The delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for government contracts. The company's extensive portfolio of federal awards demonstrates consistent capability in delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities across the nation. Xiaflex, a collagenase clostridium histolyticum product used in orthopedic and hand surgery applications, represents the type of specialized pharmaceutical product the company routinely supplies to support Department of Defense medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FUJSJ?
SPE2DB25FUJSJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FUJSJ worth?
The government has obligated $20,568 on SPE2DB25FUJSJ.
Is contract SPE2DB25FUJSJ an order under another contract?
Yes. SPE2DB25FUJSJ is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJSJ competed?
The extent of competition for SPE2DB25FUJSJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award